Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04OMK
|
||||
Former ID |
DNC010429
|
||||
Drug Name |
Nicotinaldehyde O-4-butoxyphenylcarbamoyl oxime
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530604] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H19N3O3
|
||||
Canonical SMILES |
CCCCOC1=CC=C(C=C1)NC(=O)ON=CC2=CN=CC=C2
|
||||
InChI |
1S/C17H19N3O3/c1-2-3-11-22-16-8-6-15(7-9-16)20-17(21)23-19-13-14-5-4-10-18-12-14/h4-10,12-13H,2-3,11H2,1H3,(H,20,21)/b19-13+
|
||||
InChIKey |
GPBQAYXYNOXDEZ-CPNJWEJPSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.